Loading...
Docoh

Co-Diagnostics (CODX)

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Company profile

Ticker
CODX
Exchange
CEO
Dwight Egan
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
DNA Logix, Inc. • Idaho Molecular, Inc. • Advanced Conceptions, Inc. ...

CODX stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$7.00
Low target
$5.00
High target
$9.00
HC Wainwright & Co.
Maintains
Buy
$9.00
15 Aug 22
Sidoti & Co.
Downgraded
Neutral
$5.00
12 Aug 22

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

11 Aug 22
1 Oct 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 86.05M 86.05M 86.05M 86.05M 86.05M 86.05M
Cash burn (monthly) 3.79M (no burn) 1.38M (no burn) (no burn) (no burn)
Cash used (since last report) 11.59M n/a 4.23M n/a n/a n/a
Cash remaining 74.45M n/a 81.82M n/a n/a n/a
Runway (months of cash) 19.6 n/a 59.2 n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
11 Jul 22 Ted Murphy RSU Common Stock Grant Acquire A No No 0 70,000 0 82,500
11 Jul 22 Eugene Durenard RSU Common Stock Grant Acquire A No No 0 70,000 0 82,500
11 Jul 22 James B Nelson RSU Common Stock Grant Acquire A No No 0 70,000 0 82,500
11 Jul 22 Serbin Richard S RSU Common Stock Grant Acquire A No No 0 70,000 0 82,500
6 Jun 22 Brian Lee Brown RSU Common Stock Grant Acquire A No No 0 225,000 0 306,667
11.0% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 73 82 -11.0%
Opened positions 12 15 -20.0%
Closed positions 21 14 +50.0%
Increased positions 26 24 +8.3%
Reduced positions 17 27 -37.0%
13F shares Current Prev Q Change
Total value 40.93M 42.73M -4.2%
Total shares 7.23M 6.92M +4.5%
Total puts 316.3K 352.9K -10.4%
Total calls 632.8K 419.7K +50.8%
Total put/call ratio 0.5 0.8 -40.6%
Largest owners Shares Value Change
Vanguard 2.02M $11.35M +8.1%
Renaissance Technologies 683.5K $3.83M +16.6%
MS Morgan Stanley 505.86K $2.84M +1897.1%
BLK Blackrock 501.64K $2.81M +2.9%
Bridgeway Capital Management 391.9K $2.2M +39.1%
Geode Capital Management 301.2K $1.69M +13.9%
Acadian Asset Management 238.1K $1.34M +204.4%
BK Bank Of New York Mellon 223.35K $1.25M -2.1%
Globeflex Capital L P 220.48K $1.24M NEW
Millennium Management 164.44K $922K -56.0%
Largest transactions Shares Bought/sold Change
MS Morgan Stanley 505.86K +480.53K +1897.1%
Parametric Portfolio Associates 0 -331.41K EXIT
Globeflex Capital L P 220.48K +220.48K NEW
Millennium Management 164.44K -209.02K -56.0%
Advisor Resource Council 62.65K -200.71K -76.2%
Acadian Asset Management 238.1K +159.88K +204.4%
Vanguard 2.02M +151.32K +8.1%
Engineers Gate Manager 0 -122K EXIT
Bridgeway Capital Management 391.9K +110.1K +39.1%
Renaissance Technologies 683.5K +97.45K +16.6%

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: customer, larger, percentage, provisional, remeasurement, resolution, shareholder, volume
Removed: frequently, prevent, reduction